Zokinvy®
Company
Progeria Research Foundation, Elger BioPharmaceuticals
Use
Treatment of Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies.
Features
Farnesyltransferase inhibitor to prevent defective protein buildup.
NIH Contribution
NIH research identified the potential use of Zokinvy for progeria.
HHS Institute/Agency
NHGRI
Inventor(s)
Erdos, M. et al.
Year
2021
